Announcements and Notices - [Other - Business Update]

Antengene Corporation Limited operates as a specialty pharmaceutical company. The Company produces innovative drugs, selinexor, eltanexor, verdinexor, and other products. Antengene provides its services throughout China.

Voluntary Announcement
Xpovio'S Indication In Dlbcl Successfully Included In
2024 China National Reimbursement Drug List

Voluntary Announcement
Approval Of Snda By The South Korean Ministry Of Food And
Drug Safety For Xpovio For Its Third Indication

Next Day Disclosure Return

Announcements and Notices - [Share Scheme]

Grant Of Share Options

Financial Statements/ESG Information - [Interim/Half-Year Report]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Antengene (6996 HK)

Voluntary Announcement Xpovio'S Indication In Dlbcl Successfully Included In 2024 China National Reimbursement Drug List

Voluntary Announcement Approval Of Snda By The South Korean Ministry Of Food And Drug Safety For Xpovio For Its Third Indication

Next Day Disclosure Return

Grant Of Share Options

2024 Interim Report

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)